The DOI matches its OpenAlex record.
A standard heparin nomogram for the management of heparin therapy
Abstract
A nomogram for the adjustment of heparin dosage was developed to standardize heparin therapy and to reduce delays in achieving and maintaining a therapeutic activated partial thromboplastin time (APTT) result. Fifty consecutive patients with acute venous thromboembolism had their continuous intravenous heparin therapy adjusted according to this heparin nomogram. The effect of the nomogram on heparin therapy in these patients was compared with data from 53 historical control patients. The proportion of patients in the nomogram group who reached a therapeutic APTT at 24 hours after the start of heparin therapy was 66%, which increased to 81% at 48 hours. In contrast, 37% and 58% of the control patients reached a therapeutic APTT at 24 and 48 hours, respectively. The percentage of therapeutic APTT results of the total number of APTT determinations was greater in the nomogram patients than controls. The use of this heparin nomogram resulted in (1) achieving a therapeutic APTT at 24 and 48 hours in a large proportion of patients and (2) reduced periods of inadequate anticoagulation and overanticoagulation during heparin therapy. (Arch Intern Med. 1991;151:333-337)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Hirsh, J., Warkentin, T. E., Shaughnessy, S. G., Anand, S. S., Halperin, J. L., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (2001) · Chest · doi:10.1378/chest.119.1_suppl.64s · Cited by 1,580
Antithrombotic Therapy for Venous Thromboembolic Disease
Büller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., & Raskob, G. E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.401s · Cited by 1,249
Levine, M., Gent, M., Hirsh, J., Leclerc, J., Anderson, D., Weitz, J., Ginsberg, J., Turpie, A. G., Demers, C., Kovacs, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341101 · Cited by 1,192
Self-citationGarcia, D. A., Baglin, T. P., Weitz, J. I., & Samama, M. M. (2012) · Chest · doi:10.1378/chest.11-2291 · Cited by 1,091
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., Warkentin, T. E., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (1998) · Chest · doi:10.1378/chest.114.5_supplement.489s · Cited by 1,031
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., & Raschke, R. (2004) · Chest · doi:10.1378/chest.126.3_suppl.188s · Cited by 971
Oates, J. A., Wood, A. J. J., & Hirsh, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242206 · Cited by 830
The Perioperative Management of Antithrombotic Therapy
Douketis, J. D., Berger, P. B., Dunn, A. S., Jaffer, A. K., Spyropoulos, A. C., Becker, R. C., & Ansell, J. (2008) · Chest · doi:10.1378/chest.08-0675 · Cited by 830
Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism
(1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371001 · Cited by 784
Hirsh, J., Bauer, K. A., Donati, M. B., Gould, M., Samama, M. M., & Weitz, J. I. (2008) · Chest · doi:10.1378/chest.08-0689 · Cited by 755
Antithrombotic Therapy in Neonates and Children
Monagle, P., Chalmers, E., Chan, A., deVeber, G., Kirkham, F., Massicotte, P., & Michelson, A. D. (2008) · Chest · doi:10.1378/chest.08-0762 · Cited by 676
A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes
(1996) · New England Journal of Medicine · doi:10.1056/nejm199609123351103 · Cited by 660
Hirsh, J., & Hoak, J. (1996) · Circulation · doi:10.1161/01.cir.93.12.2212 · Cited by 635
Hirsh, J., Anand, S. S., Halperin, J. L., & Fuster, V. (2001) · Circulation · doi:10.1161/01.cir.103.24.2994 · Cited by 565
Hirsh, J., Dalen, J. E., Deykin, D., & Toller, L. (1992) · Chest · doi:10.1378/chest.102.4_supplement.337s · Cited by 558
Antithrombotic Therapy in Children
Michelson, A. D., Bovill, E., Monagle, P., & Andrew, M. (1998) · Chest · doi:10.1378/chest.114.5_supplement.748s · Cited by 425
Levine, M. N. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.1.49 · Cited by 403
Antithrombotic Therapy in Children*
Monagle, P., Chan, A., Massicotte, P., Chalmers, E., & Michelson, A. D. (2004) · Chest · doi:10.1378/chest.126.3_suppl.645s · Cited by 395
Venous Thromboembolism during Pregnancy
Toglia, M. R., & Weg, J. G. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607113350207 · Cited by 387
Ross, A. M., Coyne, K. S., Reiner, J. S., Greenhouse, S. W., Fink, C., Frey, A., Moreyra, E., Traboulsi, M., Racine, N., Riba, A. L., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00444-1 · Cited by 383
Elsharawy, M., & Elzayat, E. (2002) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.2002.1665 · Cited by 373
Merli, G., Spiro, T. E., Olsson, C.-G., Abildgaard, U., Davidson, B. L., Eldor, A., Elias, D., Grigg, A., Musset, D., Rodgers, G. M., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-3-200102060-00009 · Cited by 362
Management of Venous Thromboembolism
Ginsberg, J. S. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612123352407 · Cited by 352
Establishing a Therapeutic Range for Heparin Therapy
Brill-Edwards, P., Ginsberg, J. S., Johnston, M., & Hirsh, J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-2-199307150-00002 · Cited by 329
Aspirin, Heparin, and Fibrinolytic Therapy in Suspected Acute Myocardial Infarction
Collins, R., Peto, R., Baigent, C., & Sleight, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703203361207 · Cited by 297
Granger, C. B., Hirsh, J., Califf, R. M., Col, J., White, H. D., Betriu, A., Woodlief, L. H., Lee, K. L., Bovill, E. G., Simes, R. J., et al. (1996) · Circulation · doi:10.1161/01.cir.93.5.870 · Cited by 281
Douketis, J. D., Foster, G. A., Crowther, M. A., Prins, M. H., & Ginsberg, J. S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.22.3431 · Cited by 269
Hull, R. D. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.22.2562 · Cited by 261
Optimal Therapeutic Level of Heparin Therapy in Patients With Venous Thrombosis
Hull, R. D. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.8.1589 · Cited by 260
Daskalopoulos, M. E., Daskalopoulou, S. S., Tzortzis, E., Sfiridis, P., Nikolaou, A., Dimitroulis, D., Kakissis, I., & Liapis, C. D. (2005) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2004.02.029 · Cited by 94
Metadata
- Authors
- Cruickshank, M.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association
- Published
- 1991-02-01
- Volume
- 151
- Issue
- 2
- Pages
- 333-337
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W4230948721
- Cited by
- 266
- References
- 0
- FWCI
- 16.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.